<bill session="110" type="sc" number="88" updated="2009-01-09T19:50:57-05:00">
	<status><introduced date="1213070400" datetime="2008-06-10"/></status>

	<introduced date="1213070400" datetime="2008-06-10"/>
	<titles>
		<title type="official" as="introduced">A concurrent resolution expressing the sense of Congress that the Food and Drug Administration's (FDA) new policy restricting women's access to medications containing estriol does not serve the public interest.</title>
	</titles>
	<sponsor id="300027"/>
	<cosponsors>
		<cosponsor id="300055" joined="2008-06-17"/>
		<cosponsor id="300014" joined="2008-06-10"/>
	</cosponsors>
	<actions>
		<action date="1213070400" datetime="2008-06-10"><text>Referred to the Committee on Health, Education, Labor, and Pensions.</text><reference label="text of measure as introduced" ref="CR S5455-5456"/></action>
	</actions>
	<committees>

	</committees>
	<relatedbills>

	</relatedbills>
	<subjects>

	</subjects>
	<amendments>

	</amendments>
	<summary>
	6/10/2008--Introduced.<br/>Calls for the Food and Drug Administration (FDA) to reverse its policy that aims to eliminate patient access to compounded medications containing estriol prescribed by physicians unless it holds a public comment period on the issue and can document evidence of adverse events and other safety issues to justify such policy.<br/>
	</summary>
</bill>
